Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

VJVirtual | Blood mass-spectrometry for detecting disease progression

Angela Dispenzieri, MD, of the Mayo Clinic College of Medicine, Rochester, MN, outlines the use of blood mass-spectrometry to detect immunoglobulins in amyloidosis as a measure of disease progression. This interview was recorded via an online conference call with the Video Journal of Hematological Oncology (VJHemOnc).